Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | MRSN |
---|---|---|
09:32 ET | 7437 | 4.58 |
09:34 ET | 700 | 4.59 |
09:36 ET | 780 | 4.57 |
09:38 ET | 2107 | 4.53 |
09:39 ET | 2700 | 4.49 |
09:41 ET | 600 | 4.5 |
09:43 ET | 980 | 4.518 |
09:45 ET | 3391 | 4.54 |
09:48 ET | 850 | 4.54 |
09:50 ET | 10837 | 4.62 |
09:52 ET | 10253 | 4.58 |
09:54 ET | 300 | 4.565 |
09:56 ET | 200 | 4.57 |
09:57 ET | 1400 | 4.58 |
09:59 ET | 1187 | 4.56 |
10:01 ET | 1100 | 4.575 |
10:03 ET | 4809 | 4.59 |
10:06 ET | 450 | 4.575 |
10:08 ET | 7155 | 4.6 |
10:10 ET | 300 | 4.59 |
10:12 ET | 10630 | 4.6 |
10:15 ET | 15076 | 4.58 |
10:17 ET | 4217 | 4.555 |
10:19 ET | 200 | 4.55 |
10:21 ET | 1250 | 4.545 |
10:24 ET | 15483 | 4.54 |
10:26 ET | 3179 | 4.51 |
10:28 ET | 1230 | 4.51 |
10:30 ET | 100 | 4.51 |
10:32 ET | 1503 | 4.515 |
10:33 ET | 300 | 4.515 |
10:35 ET | 2459 | 4.55 |
10:37 ET | 2550 | 4.55 |
10:39 ET | 500 | 4.55 |
10:42 ET | 6316 | 4.55 |
10:44 ET | 26515 | 4.605 |
10:46 ET | 7662 | 4.575 |
10:48 ET | 400 | 4.575 |
10:50 ET | 1600 | 4.575 |
10:51 ET | 7681 | 4.55 |
10:53 ET | 2800 | 4.55 |
10:55 ET | 5943 | 4.55 |
10:57 ET | 3707 | 4.535 |
11:00 ET | 500 | 4.535 |
11:02 ET | 200 | 4.53 |
11:04 ET | 8019 | 4.54 |
11:06 ET | 1329 | 4.56 |
11:08 ET | 700 | 4.555 |
11:09 ET | 5600 | 4.565 |
11:11 ET | 2173 | 4.575 |
11:13 ET | 1500 | 4.57 |
11:15 ET | 8570 | 4.56 |
11:18 ET | 5530 | 4.56 |
11:20 ET | 2749 | 4.565 |
11:22 ET | 7190 | 4.59 |
11:24 ET | 2194 | 4.6101 |
11:26 ET | 6496 | 4.605 |
11:27 ET | 600 | 4.61 |
11:29 ET | 900 | 4.63 |
11:31 ET | 3700 | 4.66 |
11:33 ET | 300 | 4.68 |
11:36 ET | 3390 | 4.675 |
11:38 ET | 1421 | 4.67 |
11:40 ET | 450 | 4.67 |
11:42 ET | 2555 | 4.675 |
11:44 ET | 3353 | 4.655 |
11:45 ET | 1370 | 4.66 |
11:47 ET | 900 | 4.67 |
11:49 ET | 6804 | 4.655 |
11:51 ET | 4467 | 4.64 |
11:54 ET | 3250 | 4.655 |
11:56 ET | 350 | 4.655 |
11:58 ET | 3728 | 4.6599 |
12:00 ET | 2629 | 4.65 |
12:02 ET | 1153 | 4.655 |
12:03 ET | 2390 | 4.69 |
12:05 ET | 6712 | 4.66 |
12:07 ET | 5842 | 4.685 |
12:09 ET | 2330 | 4.675 |
12:12 ET | 4719 | 4.685 |
12:14 ET | 3150 | 4.7 |
12:16 ET | 8013 | 4.67 |
12:18 ET | 2000 | 4.675 |
12:20 ET | 4300 | 4.68 |
12:21 ET | 450 | 4.6801 |
12:23 ET | 4767 | 4.675 |
12:25 ET | 1479 | 4.685 |
12:27 ET | 4087 | 4.69 |
12:30 ET | 2600 | 4.695 |
12:32 ET | 1121 | 4.6974 |
12:36 ET | 11340 | 4.68 |
12:38 ET | 1200 | 4.67 |
12:39 ET | 1460 | 4.67 |
12:41 ET | 2900 | 4.665 |
12:43 ET | 6849 | 4.685 |
12:45 ET | 2390 | 4.67 |
12:48 ET | 1100 | 4.655 |
12:50 ET | 2309 | 4.665 |
12:52 ET | 1506 | 4.67 |
12:54 ET | 3129 | 4.63 |
12:56 ET | 300 | 4.635 |
12:57 ET | 4966 | 4.63 |
12:59 ET | 1401 | 4.615 |
01:01 ET | 2579 | 4.61 |
01:03 ET | 121 | 4.615 |
01:06 ET | 1200 | 4.61 |
01:08 ET | 800 | 4.605 |
01:10 ET | 1294 | 4.61 |
01:12 ET | 1288 | 4.59 |
01:14 ET | 3345 | 4.59 |
01:15 ET | 4688 | 4.58 |
01:17 ET | 2200 | 4.575 |
01:21 ET | 2079 | 4.565 |
01:24 ET | 3758 | 4.555 |
01:26 ET | 3648 | 4.55 |
01:28 ET | 3533 | 4.56 |
01:30 ET | 999 | 4.55 |
01:32 ET | 1353 | 4.54 |
01:33 ET | 3431 | 4.55 |
01:35 ET | 2644 | 4.535 |
01:37 ET | 1200 | 4.545 |
01:39 ET | 1279 | 4.545 |
01:42 ET | 5245 | 4.56 |
01:44 ET | 1500 | 4.545 |
01:46 ET | 2956 | 4.546 |
01:48 ET | 4213 | 4.53 |
01:50 ET | 1500 | 4.545 |
01:51 ET | 900 | 4.53 |
01:53 ET | 100 | 4.535 |
01:55 ET | 705 | 4.53 |
01:57 ET | 1434 | 4.54 |
02:00 ET | 579 | 4.53 |
02:04 ET | 2136 | 4.535 |
02:06 ET | 2535 | 4.54 |
02:08 ET | 124 | 4.55 |
02:09 ET | 3690 | 4.55 |
02:11 ET | 3530 | 4.535 |
02:13 ET | 306 | 4.54 |
02:15 ET | 700 | 4.53 |
02:18 ET | 100 | 4.535 |
02:20 ET | 600 | 4.535 |
02:22 ET | 10496 | 4.545 |
02:24 ET | 400 | 4.545 |
02:26 ET | 1779 | 4.55 |
02:29 ET | 1000 | 4.545 |
02:31 ET | 1276 | 4.54 |
02:33 ET | 800 | 4.54 |
02:36 ET | 306 | 4.54 |
02:38 ET | 3849 | 4.54 |
02:40 ET | 400 | 4.55 |
02:42 ET | 2196 | 4.54 |
02:45 ET | 796 | 4.54 |
02:47 ET | 123 | 4.545 |
02:49 ET | 13190 | 4.535 |
02:51 ET | 2059 | 4.525 |
02:54 ET | 4771 | 4.53 |
02:56 ET | 1884 | 4.52 |
02:58 ET | 1200 | 4.52 |
03:00 ET | 2184 | 4.53 |
03:02 ET | 1709 | 4.54 |
03:05 ET | 4229 | 4.525 |
03:07 ET | 695 | 4.52 |
03:09 ET | 1900 | 4.53 |
03:12 ET | 1155 | 4.525 |
03:14 ET | 100 | 4.525 |
03:16 ET | 2093 | 4.515 |
03:18 ET | 2100 | 4.525 |
03:20 ET | 1317 | 4.53 |
03:21 ET | 1816 | 4.52 |
03:23 ET | 7147 | 4.505 |
03:25 ET | 817 | 4.505 |
03:27 ET | 2926 | 4.49 |
03:30 ET | 3805 | 4.485 |
03:32 ET | 4779 | 4.48 |
03:34 ET | 4248 | 4.5 |
03:36 ET | 3453 | 4.495 |
03:38 ET | 265 | 4.5 |
03:39 ET | 16533 | 4.48 |
03:41 ET | 3792 | 4.47 |
03:43 ET | 1606 | 4.49 |
03:45 ET | 300 | 4.485 |
03:48 ET | 2158 | 4.485 |
03:50 ET | 11352 | 4.475 |
03:52 ET | 7322 | 4.5 |
03:54 ET | 5009 | 4.51 |
03:56 ET | 32488 | 4.49 |
03:57 ET | 8785 | 4.49 |
03:59 ET | 29612 | 4.48 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Mersana Therapeutics Inc | 544.7M | -3.0x | --- |
Caribou Biosciences Inc | 462.4M | -3.6x | --- |
OmniAb Inc | 631.3M | -10.9x | --- |
C4 Therapeutics Inc | 552.2M | -3.1x | --- |
AnaptysBio Inc | 572.2M | -3.7x | --- |
Taysha Gene Therapies Inc | 592.8M | -2.1x | --- |
Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which is focused on the development of antibody-drug conjugates (ADCs), which offer a clinically meaningful benefit for cancer patients with significant unmet needs. It has developed two proprietary and differentiated ADC platforms: Dolasynthen and Immunosynthen. Dolasynthen is its cytotoxic ADC platform that is designed to generate site-specific, homogeneous ADCs. Immunosynthen is its proprietary stimulator of interferon genes (STING)-agonist platform that is designed to generate systemically administered ADCs that locally activate STING signaling in both antigen-expressing tumor cells and in tumor-resident immune cells. The Company's pipeline also includes XMT-1660, a Dolasynthen ADC targeting B7-H4 in a Phase I clinical trial, and XMT-2056, an Immunosynthen ADC targeting a novel epitope of human epidermal growth factor receptor 2 (HER2), in addition to other earlier-stage assets.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $544.7M |
---|---|
Revenue (TTM) | $36.9M |
Shares Outstanding | 121.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.48 |
EPS | $-1.50 |
Book Value | $0.31 |
P/E Ratio | -3.0x |
Price/Sales (TTM) | 14.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -487.51% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.